Reaction
Lipoatrophy reporting signals
As of the last recalculation, Lipoatrophy appears in 936 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 149.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Zidovudine | 82 | 149.4 | 150.3 |
| Glatiramer Acetate | 238 | 118.4 | 118.9 |
| Abacavir Sulfate | 47 | 112.9 | 113.4 |
| Lamivudine | 115 | 94.2 | 94.6 |
| Efavirenz | 43 | 89.8 | 90.2 |
| Lamivudine Oral | 77 | 73.7 | 73.9 |
| Atazanavir | 43 | 69.7 | 69.9 |
| Nevirapine | 27 | 68.5 | 68.7 |
| Ritonavir 100 Mg | 40 | 62.2 | 62.3 |
| Lopinavir And Ritonavir | 34 | 57.8 | 58.0 |
| Ritonavir | 65 | 53.1 | 53.2 |
| Tenofovir Disoproxil Fumarate Tablets | 9 | 23.4 | 23.4 |
| Asfotase Alfa | 10 | 22.4 | 22.4 |
| Methylprednisolone Acetate | 8 | 22.4 | 22.4 |
| Dolutegravir Sodium | 9 | 22.4 | 22.4 |
| Raltegravir | 15 | 20.5 | 20.5 |
| Tenofovir Disoproxil Fumarate | 29 | 20.1 | 20.1 |
| Interferon Beta-1B | 17 | 20.1 | 20.1 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 17 | 16.4 | 16.4 |
| Triamcinolone Acetonide | 22 | 16.2 | 16.2 |
| Darunavir | 10 | 14.9 | 14.9 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 5 | 11.1 | 11.1 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 22 | 11.0 | 11.0 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 5.9 | 5.9 |